Developmental and Epileptic Encephalopathy 36

Alternative Names

  • DEE36
  • Epileptic Encephalopathy, Early Infantile, 36 EIEE36
  • Congenital Disorder of Glycosylation, Type Is
  • CDG1S
  • CDG Is
  • CDGIs
Back to search Result
WHO-ICD-10 version:2010

Endocrine, nutritional and metabolic diseases

Metabolic disorders

OMIM Number

300884

Gene Map Locus

Xq23

Description

Developmental and epileptic encephalopathy-36 (DEE36) is an X-linked neurodevelopmental disorder characterized by the onset of seizures at a mean age of 6.5 months. Most patients present with infantile spasms associated with hypsarrhythmia on EEG, consistent with a clinical diagnosis of West syndrome. The seizures tend to be refractory to treatment, although some patients may respond to benzodiazepines or a ketogenic diet. Affected individuals have severely delayed psychomotor development with poor motor function, severe intellectual disability, poor or absent speech, and limited eye contact. More variable features include feeding difficulties sometimes requiring tube feeding, ocular defects including cortical visual impairment, dysmorphic facial features, and scoliosis or osteopenia. The vast majority of patients reported have been females, although rare affected males with a similar phenotype have been described. Analysis of serum transferrin typically does not show glycosylation abnormalities. [From OMIM]

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
300884.1LebanonFemaleNo SeizureNM_001099922.3:c.3330A>THeterozygousX-linkedJalkh et al. 2019
300884.2United Arab EmiratesFemaleYesNo Infantile spasms; Hypotonia; Global deve...NM_001099922.3:c.320A>GHeterozygousX-linkedBastaki et al. 2018; Hamici et al. 2017
© CAGS 2024. All rights reserved.